Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:3158-3166
doi: 10.1161/CIRCULATIONAHA.105.536102
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krumholz, H. M.
Right arrow Articles by Weintraub, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krumholz, H. M.
Right arrow Articles by Weintraub, W. S.
Related Collections
Right arrow Health policy and outcome research

(Circulation. 2005;111:3158-3166.)
© 2005 American Heart Association, Inc.


Special Report

Report of the National Heart, Lung, and Blood Institute Working Group on Outcomes Research in Cardiovascular Disease

Harlan M. Krumholz, MD, SM (Chair); Eric D. Peterson, MD, MPH (Cochair); John Z. Ayanian, MD, MPP; Marshall H. Chin, MD, MPH; Robert F. DeBusk, MD; Lee Goldman, MD, MPH; Catarina I. Kiefe, PhD, MD; Neil R. Powe, MD, MPH, MBA; John S. Rumsfeld, MD, PhD; John A. Spertus, MD, MPH; William S. Weintraub, MD

From the Departments of Medicine and of Epidemiology and Public Health (H.M.K.), Yale University School of Medicine and Yale-New Haven Health Center for Outcomes Research and Evaluation, New Haven, Conn; Duke University Medical Center and Duke Clinical Research Institute (E.D.P.), Durham, NC; Department of Medicine (J.Z.A.), Brigham and Women’s Hospital and Harvard Medical School, and the Department of Health Care Policy, Harvard Medical School, Boston, Mass; Department of Medicine (M.E.C.), Diabetes Research and Training Center, University of Chicago, Chicago, Ill; Stanford Cardiac Rehabilitation Program (R.F.D.), Stanford University School of Medicine, Stanford, Calif; Department of Medicine (L.G.), University of California, San Francisco; Department of Medicine (C.I.K.), University of Alabama at Birmingham; Welch Center for Prevention, Epidemiology, and Clinical Research (N.R.P.), Johns Hopkins Medical Institutions, Baltimore, Md; Cardiology and Health Services Research (J.S.R.), Denver Veterans Administration Medical Center, University of Colorado Health Sciences Center, Denver; University of Missouri and Mid-America Heart Institute of Saint Luke’s Hospital (J.A.S.), Kansas City, Mo; and Emory Center for Outcomes Research (W.S.W.), Emory University, Atlanta, Ga.

Correspondence to Dr Harlan M. Krumholz, Yale University School of Medicine, P.O. Box 208088, New Haven, CT 06520-8088. E-mail harlan.krumholz{at}yale.edu

Received January 14, 2005; revision received March 25, 2005; accepted March 31, 2005.

The National Heart, Lung, and Blood Institute convened a working group on outcomes research in cardiovascular disease (CVD). The working group sought to provide guidance on research priorities in outcomes research related to CVD. For the purposes of this document, "outcomes research" is defined as investigative endeavors that generate knowledge to improve clinical decision making and healthcare delivery to optimize patient outcomes. The working group identified the following priority areas: (1) national surveillance projects for high-prevalence CV conditions; (2) patient-centered care; (3) translation of the best science into clinical practice; and (4) studies that place the cost of interventions in the context of their real-world effectiveness. Within each of these topics, the working group described examples of initiatives that could serve the Institute and the public. In addition, the group identified the following areas that are important to the field: (1) promotion of the use of existing data; (2) facilitation of collaborations with other federal agencies; (3) investigations into the basic science of outcomes research, with an emphasis on methodological advances; (4) strengthening of appropriate study sections with individuals who have expertise in outcomes research; and (5) expansion of opportunities to train new outcomes research investigators. The working group concluded that a dedicated investment in CV outcomes research could directly improve the care delivered in the United States.


Key Words: outcome assessment • cardiovascular diseases • patients • statistics




This article has been cited by other articles:


Home page
CirculationHome page
H. M. Krumholz
Outcomes Research: Generating Evidence for Best Practice and Policies
Circulation, July 15, 2008; 118(3): 309 - 318.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Thomas, M. King, K. Lui, N. Oldridge, I. L. Pina, J. Spertus, R. O. Bonow, N.A. M. Estes III, D. C. Goff, K. L. Grady, et al.
AACVPR/ACC/AHA 2007 Performance Measures on Cardiac Rehabilitation for Referral to and Delivery of Cardiac Rehabilitation/Secondary Prevention Services: Endorsed by the American College of Chest Physicians, American College of Sports Medicine, American Physical Therapy Association, Canadian Association of Cardiac Rehabilitation, European Association for Cardiovascular Prevention and Rehabilitation, Inter-American Heart Foundation, National Association of Clinical Nurse Specialists, Preventive Cardiovascular Nurses Association, and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., October 2, 2007; 50(14): 1400 - 1433.
[Full Text] [PDF]


Home page
PsychosomaticsHome page
S. S. Pedersen, E. J. Martens, J. Denollet, and A. Appels
Poor Health-Related Quality of Life Is a Predictor of Early, But Not Late, Cardiac Events After Percutaneous Coronary Intervention
Psychosomatics, August 1, 2007; 48(4): 331 - 337.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
S. S Pedersen, D. A. Theuns, A. Muskens-Heemskerk, R. A. Erdman, and L. Jordaens
Type-D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life 3 months post-implantation
Europace, August 1, 2007; 9(8): 675 - 680.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
A. E. Aquarius, J. Denollet, J. F. Hamming, D. P. Van Berge Henegouwen, and J. De Vries
Type-D Personality and Ankle Brachial Index as Predictors of Impaired Quality of Life and Depressive Symptoms in Peripheral Arterial Disease
Arch Surg, July 1, 2007; 142(7): 662 - 667.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. C. Goff Jr, L. Brass, L. T. Braun, J. B. Croft, J. D. Flesch, F. G.R. Fowkes, Y. Hong, V. Howard, S. Huston, S. F. Jencks, et al.
Essential Features of a Surveillance System to Support the Prevention and Management of Heart Disease and Stroke: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Stroke, and Cardiovascular Nursing and the Interdisciplinary Working Groups on Quality of Care and Outcomes Research and Atherosclerotic Peripheral Vascular Disease
Circulation, January 2, 2007; 115(1): 127 - 155.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
L. F. Souza
Anesthesia research needs definitions.
Anesth. Analg., April 1, 2006; 102(4): 1287 - 1287.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster
Symposium Presentations
J. Am. Coll. Cardiol., October 4, 2005; 46(7_Suppl_A): 5A - 70A.
[Full Text] [PDF]


Home page
JAMAHome page
E. D. Peterson
Optimizing the Science of Quality Improvement
JAMA, July 20, 2005; 294(3): 369 - 371.
[Full Text] [PDF]